← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #727 OF 1,000 MOST-CITED

Adequate and readily accessible

FDA cited this observation 22 times across 21 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Parts 1240 and 125022
BY FISCAL YEAR
FY20263
FY20252
FY20243
FY20232
FY20196
FY20185
FY20171

How FDA worded it — real examples

Adequate essential sanitary facilities for use of employees are not readily accessible adjacent to areas where air conveyances are serviced.

Charles M. Schulz Sonoma County Airport · Santa Rosa, California · Parts 1240 and 1250 · 2026-06-30

Adequate essential sanitary facilities for use of employees are not readily accessible adjacent to areas where air conveyances are serviced and maintained.

State of Hawaii Department of Transportation Airports Division - Hilo · Hilo, Hawaii · Parts 1240 and 1250 · 2026-05-20

Adequate washroom facilities for use of employees are not readily accessible adjacent to areas where land conveyances are serviced.

Montrose Regional Airport · Montrose, Colorado · Parts 1240 and 1250 · 2025-11-06

Adequate essential sanitary facilities for use of employees are not readily accessible adjacent to places and areas where air conveyances are serviced, maintained and cleaned.

Charlotte County Airport Authority · Punta Gorda, Florida · Parts 1240 and 1250 · 2025-06-27

Adequate washroom and essential sanitary facilities for use of employees are not readily accessible adjacent to areas where air conveyances are serviced.

Southwest Airlines, Inc. · Albuquerque, New Mexico · Parts 1240 and 1250 · 2024-11-22

Adequate washroom facilities for use of employees are not readily accessible adjacent to areas where air conveyances are serviced.

Jet Aviation Associates, Ltd. · West Palm Beach, Florida · Parts 1240 and 1250 · 2024-08-21

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →